Kallikrein and kinin receptor expression in inflammation and cancer.
about
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegenerationKinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processesEffects of the demethylating agent, 5-azacytidine, on expression of the kallikrein-kinin genes in carcinoma cells of the lung and pleuraQuantitative analysis of protein and gene expression in salivary glands of Sjogren's-like disease NOD mice treated by bone marrow soupKinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisationRole of G protein-coupled receptors in inflammation.Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.Role of human tissue kallikrein in gastrointestinal stromal tumour invasion.Human tissue kallikreins: a new enzymatic cascade pathway?The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (Cavia porcellus).The bradykinin B(2) receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines.Cellular distribution of human tissue kallikreins: immunohistochemical localization.Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.Intestinal tissue kallikrein-kinin system in inflammatory bowel disease.Kinin receptors as targets for cancer therapy.The enhanced permeability retention effect: a new paradigm for drug targeting in infection.The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.Passive targeting of nanoparticles to cancer: A comprehensive review of the literature.Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer.Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma.Functional and molecular characterization of kinin B1 and B 2 receptors in human bladder cancer: implication of the PI3Kγ pathway.Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.Autoimmunity against a tissue kallikrein in IQI/Jic Mice: a model for Sjogren's syndrome.Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma.Kallikreins and lupus nephritis.Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues.Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.
P2860
Q24643613-63C706FF-3B53-4792-B5A0-91FA3898413FQ24671067-611AF950-0BD2-4A61-8E3F-F57D4434E2AAQ28391556-2370CA46-B3FF-4B6A-AD01-A03A4ED85315Q28539302-FEBB4EA1-F738-4C0A-8322-041ECBAE9B37Q28575445-0B166D70-380A-47ED-8232-ABA9876D663AQ33858841-8D5EBDE0-905C-4AE5-8241-0197A50AF78AQ33898338-33B42622-6862-4E20-8F3D-7C7D034686BBQ34087004-F4B56E33-17C4-46CB-BF80-782469E047FEQ34344121-B5966984-FCF8-485E-B025-A6041585050AQ35000702-BF952DB3-BE33-4F42-93D1-8AFE1ADEB422Q35861497-25320954-6111-4991-8D14-9DD6FAB9BF25Q35915727-131A8B03-5D21-4A82-B8D8-137A44C9FF2CQ36171256-7E4D520E-04B6-4397-BF1B-C5D9E54CD753Q36519359-CC07B5C6-75AC-49F4-B393-23548D292FBEQ37217423-5E4913F9-C5C4-43AA-8C08-EE3423E121BBQ37697813-94DAEE48-D63C-4E34-AEA3-8BFC9A30A1A9Q37789692-8B399143-F519-463D-A417-657AF107DC2CQ37984531-053D3A22-478C-42AA-AA34-CE2007C51490Q38051263-39611F6A-F14F-494C-BD61-B27F928D66F7Q38089750-038B3382-AC17-41B6-A32D-D5D19CFF83AFQ38256388-59E7BBB8-85E5-4D0B-8B13-7348B704CC5CQ38425301-8D608BCE-3EBE-4AE2-8709-A88E3E22E687Q38429421-548FB139-5F47-4AA1-99AD-6BA2A9B2D149Q39229824-CA9E7392-4711-442B-BAEE-4F74AD26EBCEQ40262739-4E93D204-2D9A-4F5A-9509-6BC8842B14D3Q41763769-D0495A62-7D46-4B0F-97BA-C885D1DC94C7Q42640603-FD181831-6B51-41A4-A083-2FD0922FCF33Q43010073-336E6DD0-A0F6-483E-81AC-4506AB4C25E2Q43108125-F966D8F5-E35B-4935-869B-87951DE4FDBCQ45714406-76FF1A5A-60A5-4152-ADD3-2FECC87B91A1Q46404967-F34668BF-3E2C-4E16-8221-03849B51006DQ55240138-1B65145C-BAE2-4EB6-975B-4225D34A101C
P2860
Kallikrein and kinin receptor expression in inflammation and cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Kallikrein and kinin receptor expression in inflammation and cancer.
@en
Kallikrein and kinin receptor expression in inflammation and cancer.
@nl
type
label
Kallikrein and kinin receptor expression in inflammation and cancer.
@en
Kallikrein and kinin receptor expression in inflammation and cancer.
@nl
prefLabel
Kallikrein and kinin receptor expression in inflammation and cancer.
@en
Kallikrein and kinin receptor expression in inflammation and cancer.
@nl
P2093
P2860
P356
P1433
P1476
Kallikrein and kinin receptor expression in inflammation and cancer.
@en
P2093
P2860
P356
10.1515/BC.2001.013
P577
2001-01-01T00:00:00Z